GB2417900A — Composition for oral drug delivery
Assigned to MEDWAY SCIENCE TECHNOLOGIES LT · Expires 2006-03-15 · 20y expired
What this patent protects
A method of blending naturally occurring polymers with taste masking agents in a supercritical fluid, comprising the steps of forming a mixture of the supercritical fluid, the polymer, the taste masking agent and an active substance, allowing the polymer, taste masking agent, and…
USPTO Abstract
A method of blending naturally occurring polymers with taste masking agents in a supercritical fluid, comprising the steps of forming a mixture of the supercritical fluid, the polymer, the taste masking agent and an active substance, allowing the polymer, taste masking agent, and active substance to interact to form a complex, and separating the particles from the supercritical fluid. The method for combining the polymers within the supercritical fluid may form a supramolecular complex. A method whereby any step incorporating a supercritical fluid is achieved in the supercritical state is also disclosed.
Drugs covered by this patent
- Arthrotec (Diclofenac Sodium) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.